JP2022527395A5 - - Google Patents
Info
- Publication number
- JP2022527395A5 JP2022527395A5 JP2021559883A JP2021559883A JP2022527395A5 JP 2022527395 A5 JP2022527395 A5 JP 2022527395A5 JP 2021559883 A JP2021559883 A JP 2021559883A JP 2021559883 A JP2021559883 A JP 2021559883A JP 2022527395 A5 JP2022527395 A5 JP 2022527395A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- independently
- pharmaceutically acceptable
- conditions
- diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962831753P | 2019-04-10 | 2019-04-10 | |
| US62/831,753 | 2019-04-10 | ||
| PCT/US2020/027203 WO2020210308A1 (en) | 2019-04-10 | 2020-04-08 | Small molecule inhibitors of galectin-3 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022527395A JP2022527395A (ja) | 2022-06-01 |
| JP2022527395A5 true JP2022527395A5 (cg-RX-API-DMAC10.html) | 2023-04-17 |
| JP7577682B2 JP7577682B2 (ja) | 2024-11-05 |
Family
ID=70476468
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021559883A Active JP7577682B2 (ja) | 2019-04-10 | 2020-04-08 | ガレクチン-3の低分子阻害剤 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12269819B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP3953349A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP7577682B2 (cg-RX-API-DMAC10.html) |
| KR (1) | KR102890853B1 (cg-RX-API-DMAC10.html) |
| CN (1) | CN113710665A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2020210308A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102863667B1 (ko) | 2019-08-09 | 2025-09-23 | 이도르시아 파마슈티컬스 리미티드 | (2-아세트아미딜)티오-베타-d-갈락토피라노시드 유도체 |
| US12404295B2 (en) | 2019-08-09 | 2025-09-02 | Idorsia Pharmaceuticals Ltd | (Hetero)aryl-methyl-thio-beta-D-galactopyranoside derivatives |
| MA56883B1 (fr) | 2019-08-15 | 2025-04-30 | Idorsia Pharmaceuticals Ltd | Dérivés de 2-hydroxycycloalcane-1-carbamoyle |
| CN114585619B (zh) | 2019-08-29 | 2024-09-27 | 爱杜西亚药品有限公司 | α-D-吡喃半乳糖苷衍生物 |
| WO2021231243A1 (en) * | 2020-05-11 | 2021-11-18 | Bristol-Myers Squibb Company | Small molecule inhibitors of galectin-3 |
| WO2022073969A1 (en) | 2020-10-06 | 2022-04-14 | Idorsia Pharmaceuticals Ltd | Spiro derivatives of alpha-d-galactopyranosides |
| US12291520B2 (en) | 2020-11-02 | 2025-05-06 | Idorsia Pharmaceuticals Ltd | Galectin-3 inhibiting 2-hydroxycycloalkane-1-carbamoyl derivatives |
| JP7844491B2 (ja) | 2021-02-09 | 2026-04-13 | イドルシア・ファーマシューティカルズ・リミテッド | ヒドロキシヘテロシクロアルカン-カルバモイル誘導体 |
| WO2022184755A1 (en) * | 2021-03-03 | 2022-09-09 | Idorsia Pharmaceuticals Ltd | Triazolyl-methyl substituted alpha-d-galactopyranoside derivatives |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0401300D0 (sv) | 2004-05-21 | 2004-05-21 | Forskarpatent I Syd Ab | Novel Galactoside Inhibitors of Galectins |
| SE0401301D0 (sv) | 2004-05-21 | 2004-05-21 | Forskarpatent I Syd Ab | Novel 3-triazolyl-galactoside inhibitors of galectins |
| US9021050B2 (en) | 2012-08-31 | 2015-04-28 | Yume, Inc. | Network service system and method with off-heap caching |
| KR102231732B1 (ko) | 2012-10-10 | 2021-03-23 | 갈렉틴 테라퓨틱스, 인크. | 당뇨병성 신장병증 및 관련 질환의 치료를 위한 갈락토스 갈래의 탄수화물 화합물 |
| IN2015DN02573A (cg-RX-API-DMAC10.html) | 2012-10-31 | 2015-09-11 | Galecto Biotech Ab | |
| CA2970062C (en) | 2015-01-30 | 2023-02-28 | Galecto Biotech Ab | Alpha-d-galactoside inhibitors of galectins |
| JP6844991B2 (ja) | 2015-11-10 | 2021-03-17 | サンコ テキスタイル イスレットメレリ サン ベ ティク エーエスSanko Tekstil Isletmeleri San. Ve Tic. A.S. | ジッパーを有する伸縮性衣類の製法 |
| KR102626669B1 (ko) | 2017-05-12 | 2024-01-17 | 갈랙틴 사이언시즈, 엘엘씨 | 질환의 예방 및 치료를 위한 화합물 및 이의 용도 |
| CA3062649A1 (en) * | 2017-05-12 | 2018-11-15 | Galectin Sciences, Llc | Compounds for the treatment of systemic insulin resistance disorders and the use thereof |
| US11267811B2 (en) * | 2017-09-27 | 2022-03-08 | Bristol-Myers Squibb Company | Small molecule inhibitors of galectin-3 |
-
2020
- 2020-04-08 US US17/601,942 patent/US12269819B2/en active Active
- 2020-04-08 KR KR1020217036227A patent/KR102890853B1/ko active Active
- 2020-04-08 WO PCT/US2020/027203 patent/WO2020210308A1/en not_active Ceased
- 2020-04-08 EP EP20722856.0A patent/EP3953349A1/en active Pending
- 2020-04-08 JP JP2021559883A patent/JP7577682B2/ja active Active
- 2020-04-08 CN CN202080027684.8A patent/CN113710665A/zh active Pending